Deep Vein Thrombosis-primed neutrophils reshape the brain microenvironment to promote brain metastasis
This study identifies deep vein thrombosis (DVT) as an independent risk factor that promotes triple-negative breast cancer brain metastasis by reprogramming circulating neutrophils to enhance their recruitment to the brain and formation of neutrophil extracellular traps (NETs), thereby reshaping the brain microenvironment to support metastatic growth.
Original paper dedicated to the public domain under CC0 1.0 (https://creativecommons.org/publicdomain/zero/1.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
When cancer spreads from its original site to other parts of the body, the brain is often the most dangerous destination. For patients with a particularly aggressive form of breast cancer, the arrival of tumor cells in the brain is frequently a fatal event, with survival measured in mere months. While doctors have long known that cancer cells must travel through the bloodstream to reach the brain, the conditions that make this journey successful have remained a mystery. It is now clear that the body's own immune system plays a complex role in this process. Among the many types of white blood cells that patrol the body, neutrophils act as rapid responders to injury and infection. However, these cells can sometimes be tricked into helping cancer rather than fighting it. Another critical factor in the lives of cancer patients is the development of blood clots, a common complication known as deep vein thrombosis. While these clots are dangerous on their own, a new line of inquiry suggests they might also be silently reshaping the body's internal landscape in ways that invite cancer to the brain.
A team of researchers at the National Institutes of Health set out to investigate a troubling connection they had noticed in patient records: women with metastatic breast cancer who developed deep vein thrombosis were significantly more likely to develop brain metastases than those who did not. To understand if this was a coincidence or a cause-and-effect relationship, the scientists turned to a living model. They used mice that had been injected with breast cancer cells designed to seek out the brain, similar to how the disease behaves in humans. Three days after injecting the cancer cells, the researchers induced a blood clot in the lower body of some mice, mimicking the deep vein thrombosis seen in patients, while others underwent a sham procedure that did not create a clot. They then waited to see what happened inside the brains of these animals.
The results were striking. The mice with the induced blood clots developed far more extensive brain tumors than the mice without clots. In fact, the area of the brain occupied by cancer cells was up to three times larger in the clot group. Crucially, the blood clots did not make the primary tumor grow faster, nor did they help the cancer spread to the lungs. This indicated that the blood clot was not simply making the cancer more aggressive everywhere; instead, it was specifically preparing the brain to accept the invading cells. The researchers then looked closely at the brain tissue to see what had changed. They found that the brains of the mice with clots were flooded with neutrophils, a type of white blood cell that had been drawn there from the rest of the body. In the mice without clots, these cells were far less common.
To prove that these neutrophils were the true culprits, the scientists performed a delicate experiment. They treated a group of mice with an antibody that temporarily removed neutrophils from their circulation just as the cancer cells were arriving in the brain. When they did this, the blood clots lost their power. The mice with clots but without neutrophils developed brain tumors at the same low rate as the mice without clots. This confirmed that the blood clot itself was not directly feeding the cancer; rather, it was sending out a signal that mobilized neutrophils, which then went on to help the cancer take hold.
The researchers then asked how the blood clot changed these neutrophils so that they became so helpful to the cancer. By analyzing the genetic instructions inside the cells, they discovered that the clot had reprogrammed the neutrophils. These cells were no longer just sitting in the blood; they were being primed to move quickly and aggressively. Specifically, the clot caused the neutrophils to produce more of a surface protein called CXCR2, which acts like a magnet, pulling the cells toward the blood vessels in the brain. Once there, the neutrophils did not just sit passively. They began to form a web-like structure known as a neutrophil extracellular trap. These traps are made of DNA and enzymes that the cell releases into the surrounding space. In the context of this study, these traps appeared to create a welcoming environment for the cancer cells, helping them survive and grow once they arrived in the brain.
The study also looked at a large database of real-world patient records to see if the mouse findings held true in people. After carefully matching patients to ensure they were similar in age, race, and other health conditions, the researchers found that women with metastatic breast cancer who had a history of deep vein thrombosis were nearly twice as likely to develop brain metastases as those who did not. This statistical link, combined with the biological evidence from the mice, suggests a clear pathway: a blood clot in the leg or pelvis can trigger a chain reaction that travels through the bloodstream, alters the behavior of immune cells, and ultimately makes the brain a much more hospitable place for cancer to grow.
This discovery shifts the way scientists view the relationship between blood clots and cancer. Rather than seeing a clot merely as a separate complication or a sign that a patient is very sick, the findings suggest the clot itself is an active driver of the disease. It acts as a systemic signal that reprograms the body's defenses, turning them into tools that aid the spread of cancer to the brain. While the study does not yet offer a new treatment, it points to a specific mechanism that could be targeted in the future. If doctors could stop the neutrophils from being reprogrammed or prevent them from forming those DNA webs, they might be able to break the link between blood clots and brain metastasis, potentially saving lives by keeping the brain off-limits to the cancer.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.